Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice

Publisher:
John Wiley & Sons Ltd
Publication Type:
Journal Article
Citation:
Journal Of Gene Medicine, 2006, 8 (9), pp. 1086 - 1096
Issue Date:
2006-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2010000580OK.pdf1.23 MB
Adobe PDF
Background We aimed to evaluate the efficacy of gene-directed enzyme-prodrug therapy (GDEPT) using cytosine deaminase in combination with uracil phosphoribosyl transferase (CDUPRT) against intraprostatic mouse androgen-refractory prostate (RM1) tumors in
Please use this identifier to cite or link to this item: